Colin C. Pritchard MD, PhD

Colin C. Pritchard, MD, PhD

University of Washington

Seattle, Washington

Dr. Pritchard is an Associate Professor of Genetics in the Department of Laboratory Medicine at the University of Washington (UW) in Seattle. He also serves as Head of the Genetics Division of Laboratory Medicine at UW Medicine, Director of Clinical Diagnostics for the Brotman Baty Institute for Precision Medicine, and Co-Director of the Genetics and Solid Tumors Laboratory at the University of Washington Medical Center, a facility that services the Seattle Cancer Care Alliance (SCCA). Dr. Pritchard also undertook his graduate and medical training at the University of Washington.

The Pritchard Laboratory focuses on oncology molecular diagnostics, particularly the source and utility of cell-free nucleic acid biomarkers in blood, and the development of innovative molecular diagnostics for the identification of DNA repair gene mutations that can guide therapeutic decision-making. His clinical work focuses on applications of next-generation sequencing gene panels for cancer risk assessment and precision treatment. He has led the development and implementation of the ColoSeq™ Lynch and Polyposis Syndrome Panel and UW-OncoPlex™ Cancer Gene Panel, both of which are in current clinical use for cancer patients and their families.

Disclosures:

Talks by Colin C. Pritchard, MD, PhD

Molecular Insights into the Germline for Prostate Cancer Initiation, Progression, and Aggressiveness

Posted by Colin C. Pritchard, MD, PhD | Jan 2020

Colin C. Pritchard, MD, PhD, director of the Genetics and Solid Tumors Laboratory at the University of Washington Medical Center, discusses how germline testing and next-generation sequencing (NGS) of tumors have become important for guiding prostate cancer diagnosis, treatment, and assessment of risk. He details DNA damage response (DDR) genes, including key pathways, potential risk factors, and general characteristics. He also discusses the role of molecular pathologists in testing samples, choosing methodology, and interpreting results.

Colin C. Pritchard, MD, PhD

University of Washington

Seattle, Washington

Talks by Colin C. Pritchard, MD, PhD

Molecular Insights into the Germline for Prostate Cancer Initiation, Progression, and Aggressiveness

Join the GRU Community

You have Successfully Subscribed!